Uromitexan 100 (Mesna Vials) 100mg

Uromitexan 100 contains mesna, used to reduce bladder irritation during chemotherapy. This 100mg vial helps protect the urinary tract from certain cancer treatments. Ideal for patients seeking supportive care during therapy. Mesna is a well-established agent for this purpose.

Strength

100mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Zydus

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mesna is primarily used to prevent bladder damage caused by chemotherapy drugs like ifosfamide or cyclophosphamide. It works by binding to harmful metabolites in the urine, reducing irritation and inflammation. Patients undergoing these treatments often require mesna to maintain urinary health. This medication is not a cancer treatment itself but supports the body during therapy.

Side Effects

Mesna helps neutralize bladder-irritating substances that can form during chemotherapy. By protecting the bladder lining, it may reduce discomfort such as burning or frequent urination. Some patients report feeling less urgency or pain during treatment. Its effects are typically observed within hours of administration.

Precautions & Warnings

Store mesna at room temperature away from moisture and heat. Keep out of reach of children and pets. Patients should stay hydrated while using this medication to support its protective effects. Inform your healthcare provider about any existing kidney or bladder conditions before use.

Avoid Interactions

Mesna may interact with other medications that affect the kidneys or bladder. Alcohol and certain pain relievers could increase bladder irritation. Always disclose all medications to your doctor to avoid potential conflicts. No major drug-to-drug interactions are widely reported, but caution is advised with kidney-active drugs.

Frequently Asked Questions

It is used to reduce bladder irritation caused by certain chemotherapy drugs.

Mesna is typically given as an injection by a healthcare professional during chemotherapy.

Consult your doctor before combining mesna with other drugs, especially those affecting the kidneys.

Some patients may experience mild nausea, headache, or dizziness during treatment.

Its use is generally short-term, tied to chemotherapy cycles. Long-term safety should be discussed with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.